Xvivo Perfusion AB (publ)

kr 197.50As of Sun 8 Nov 2026, 12:00 UTC
STO:XVIVOHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR 10.40%
Div yield —
ROE 5.91%
Medical Devices
Beta (5Y) 1.47
PE TTM 48.29
TSR TTM 4.22%
Mkt cap kr 6.221B
ROIC 5.17%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 241
21.95%
231.47%
Hold 12|9|7|4|9
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
4.19
4.65
4.54
4.80
23.45%
27.20%
20.77%
15.55%
Revenuekr M
401.0
402.3
406.0
402.3
10.43%
11.34%
8.29%
4.36%
Peers (US$629.0M)
Cap (US$)
PE
1.386B
20.37x
849.4M
30.65x
479.9M
34.42x
Capital
TTM
5Y
10Y
Leveragex
3.328
0.062
0.040
EBIT/Intx
0.352
0.658
0.550
Own earn%
(200.90)
57.80
80.69
Sh yield%
54.67
16.59
17.58
Owners
Insiders/Inst%
14.56
21.30
Short interest%
1.87
SBC / revenue%
0.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
0–5
$1 testx
0.0
Incr. ROIC%
6